← Back to Patent Explorer
US4136186A Expired / Lapsed US ⏱️ 0.0 years remaining

Thieno[3,2-c]pyridine derivatives

Assignee: Parcor SARL
•
Filing: 1977-01-13
•
Granted: 1979-01-23
•
Expires: 1997-01-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to thieno[3,2-c]pyridine derivatives having the formula: ##STR1## in which: R 1 represents an alkyl radical having 1-6 carbon atoms; R 2 represents a radical selected from hydrogen and an acyl group; R 3 represents a radical selected from hydrogen; an acyl group; an alkoxycarbonyl group; a phenyl group; a phenyl group substituted with at least a substitutent selected with at least a substituent selected from halogen, hydroxy, nitro, amino, cyano, carboxy, alkoxycarbonyl, C 1-6 alkyl, C 1-6 alkoxy; a phenoxy group; a phenoxy group substituted with at least a substituent selected from halogen, hydroxy, nitro, amino, cyano, carboxy, alkoxycarbonyl, C 1-6 alkyl, and C 1-6 alkoxy; and a trifluoromethyl group; R 4 represents hydrogen, an acyl group, an alkoxy carbonyl group, or a phenyl or phenoxy group optionally substituted with at least a halogen atom or a hydroxy, nitro, amino, cyano, carboxy, alkoxycarbonyl, C 1-6 alkyl, C 1-6 alkoxy group, or a trifluoromethyl group, and N is an integer from 0 to 15; and their pharmaceutically acceptable acid addition salts. Said derivatives have an inhibiting activity on blood-platelet aggregation, and anti-inflammator and sedative activities.

Inventors

  • 👤 Daniel Frehel
  • 👤 Jean-Pierre Maffrand

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 13:59
CPC Classifications
C; C07; C07D; C07D495/00; C07D495/02; C07D495/04; A; A61; A61P; A61P25/00; A61P25/20; A61P29/00; A61P7/00; A61P7/02; C07D211/00; C07D211/04; C07D211/68; C07D211/72; C07D211/78

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 63 words
A thieno[3,2-c]pyridine derivative selected from a compound having the formula: ##STR5## in which: R 1 is alkyl having 1-6 carbon atoms; R 2 is hydrogen; R 3 is hydrogen; R 4 is a radical selected from hydrogen, benzoyl, phenyl, and phenyl substituted with a halogen atom; and n is an integer from 0 to 2; and a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 63 words
A thieno[3,2-c]pyridine derivative selected from a compound having the formula: ##STR5## in which: R 1 is alkyl having 1-6 carbon atoms; R 2 is hydrogen; R 3 is hydrogen; R 4 is a radical selected from hydrogen, benzoyl, phenyl, and phenyl substituted with a halogen atom; and n is an integer from 0 to 2; and a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 31 words
Therapeutic composition having an inhibiting activity on blood-platelet aggregation, comprising, as active ingredient, a therapeutically effective amount of a compound as claimed in claim 1, together with a therapeutically acceptable carrier.
Claim 4
Dependent Claim 27 words
Therapeutic composition having antiinflammatory activity, comprising, as active ingredient, a therapeutically effective amount of a compound as claimed in claim 1, together with a therapeutically acceptable carrier.
Claim 5
Dependent Claim 27 words
Therapeutic composition having sedative activity, comprising, as active ingredient, a therapeutically effective amount of a compound as claimed in claim 1, together with a therapeutically acceptable carrier.

References Cited (Backward Citations)

US4051141A Cited
US4075215A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-01-22 1982-07-24 1983-01-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-01-22 1986-07-24 1987-01-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-01-22 1990-07-24 1991-01-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag